CC
TNGX icon

Corton Capital’s Tango Therapeutics TNGX Stock Holding History

Corton Capital’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$95.7K Buy
+11,387
New +$77.1K 0.24% 176
2025
Q1 		– Sell
-24,408
Closed -$75.4K – 402
2024
Q4 		$75.4K Buy
+24,408
New +$113K 0.04% 358
2024
Q2 		– Sell
-15,779
Closed -$125K – 742
2024
Q1 		$125K Sell
15,779
-1,987
-11% -$21.3K 0.05% 463
2023
Q4 		$176K Buy
+17,766
New +$154K 0.06% 496

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corton Capital's TNGX Position: Q3 2025 in Review

Corton Capital opened a new position in Tango Therapeutics (TNGX) in Q3 2025: 11,387 shares worth $95.7K. The stake represents 0.24% of the portfolio and ranks #176 among its holdings. This is a return to the name: Corton Capital previously reported a position in TNGX as recently as Q4 2024.

Corton Capital first reported a position in TNGX in Q4 2023 and has held it in 4 quarters since. The position peaked at $176K in Q4 2023. 141 funds tracked by Wall St. Rank hold TNGX as of Q3 2025.

  • Corton Capital held 11,387 shares of Tango Therapeutics worth $95.7K as of Q3 2025.
  • Tango Therapeutics was a new Corton Capital position in Q3 2025.
  • Tango Therapeutics made up 0.24% of Corton Capital's portfolio in Q3 2025, its #176 holding.
  • Corton Capital first reported a position in Tango Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Corton Capital's Tango Therapeutics position peaked at $176K in Q4 2023.
  • 141 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.